Page 102 - 《中国药房》2026年1期
P. 102

临床药师主导的T2DM患者全周期管理模式构建                                                      Δ



          蒋媛媛    1, 2* ,郑桂梅 ,曹耀华 ,谢泽宇 ,曹伟灵 (1.大理大学药学院,云南 大理 671000;2.深圳市罗湖区人民
                                                     2 #
                                            2
                                    2
                            2
          医院药学部,广东 深圳 518000)
          中图分类号  R95      文献标志码  A      文章编号  1001-0408(2026)01-0092-07
          DOI  10.6039/j.issn.1001-0408.2026.01.17

          摘   要  目的  构建临床药师主导的2型糖尿病(T2DM)患者全周期管理模式。方法  基于文献分析,初步构建临床药师主导的
          T2DM患者全周期管理模式的基本框架与条目;采用德尔菲法向26名专家进行函询,确定该模式的具体实施条目;运用层次分析
         (AHP)法确定各级条目的权重,并对模式条目进行信效度分析。结果  两轮专家函询的问卷回收率分别为86.67%、100%,专家权
          威系数为0.88;三级条目的肯德尔协调系数分别为0.064、0.084(χ 检验的P值均小于0.05);AHP模型各层级判断矩阵的一致性比
                                                             2
          率均小于0.1。所建临床药师主导的T2DM患者全周期管理模式包含3个一级条目(T2DM患者住院期间的药学服务路径、T2DM
          住院患者的低血糖药学管理路径、T2DM出院患者的药学随访路径,权重分别为0.098、0.568、0.334)、12个二级条目(住院1~2 d
          的药学服务、入院评估及宣教等,权重为 0.143~0.333)和 37 个三级条目(依从性评估、核查出院带药方案等,权重为 0.068~
          0.750)。该模式上述一级条目及总体的Cronbach’s α系数分别为0.762、0.879、0.928、0.951,条目水平、量表水平的内容效度指数
          分别为0.967、0.808。结论  成功构建了临床药师主导的T2DM患者全周期管理模式,该模式具有较高的科学性与可靠性。
          关键词  临床药师;2型糖尿病;全周期管理模式;德尔菲法;层次分析法

          Construction of a full-cycle management model for T2DM patients led by clinical pharmacists
          JIANG Yuanyuan ,ZHENG Guimei ,CAO Yaohua ,XIE Zeyu ,CAO Weiling(1.  College  of  Pharmacy,  Dali
                                                        2
                                           2
                         1, 2
                                                                                 2
                                                                   2
          University, Yunnan Dali 671000, China;2. Dept. of Pharmacy, Shenzhen Luohu People’s Hospital, Guangdong
          Shenzhen 518000, China)
          ABSTRACT    OBJECTIVE  To  establish  a  full-cycle  management  model  for  type  2  diabetes  mellitus (T2DM)  patients  led  by
          clinical pharmacists. METHODS Based on literature research, a basic framework and items of full-cycle management model led by
          clinical pharmacists were initially formulated. The Delphi method was adopted to conduct questionnaire inquiries among 26 experts
          to determine the specific implementation items of the model. The analytic hierarchy process (AHP) method was used to determine
          the weight values of items at all levels, and the reliability and validity of the model items were analyzed. RESULTS The recovery
          rates  of  the  two  rounds  of  expert  consultation  questionnaires  were  86.67%  and  100%,  respectively,  and  the  expert  authority
          coefficient  was  0.88.  Kendall’s  concordance  coefficients  of  the  tertiary-level  items  were  0.064  and  0.084,  respectively,  and  the  P
          values from the χ  tests were all less than 0.05; the consistent ratios of the judgment matrices for all levels of AHP model were all
                        2
          less  than  0.1.  The  established  full-cycle  management  led  by  clinical  pharmacists  comprised  three  primary-level  items (pharmacy
          service  pathway  for T2DM  patients  during  hospitalization,  pharmacy  management  pathway  for  hypoglycemia  in T2DM  inpatients,
          and the pharmacy follow-up pathway for T2DM discharged patients, with weights of 0.098, 0.568 and 0.334, respectively), twelve
          secondary-level  items (e.g.  pharmaceutical  care  during  hospitalization  for  1  to  2  days,  admission  assessment  and  education,  with
          weights  ranging  from  0.143  to  0.333)  and  thirty-seven  tertiary-level  items (e.g.  assessment  of  medication  compliance,  verification
          of the medication plan for discharge, with weights ranging from 0.068 to 0.750). Cronbach’s α coefficients for primary-level items
                                                              and  the  overall  questionnaire  were  0.762,  0.879,  0.928  and
              Δ 基金项目 国家卫生健康委能力建设和继续教育中心2025年度                 0.951,  respectively.  The  item-level  and  scale-level  content
          慢病管理研究课题(No.GWJJMB202510041123);广东省医学科研基            validity  indexes  were  0.967  and  0.808,  respectively.
          金项目(No.202507141003106685);深圳市医疗卫生三名工程项目            CONCLUSIONS  A  full-cycle  management  model  for  T2DM
         (No.SZSM202301035);深圳市罗湖区人民医院临床研究项目(No.              patients  led  by  clinical  pharmacists  has  been  constructed
          LCYJ202203)                                         successfully, demonstrating high scientificity and reliability.
             * 第一作者 硕 士 研 究 生 。 研 究 方 向 :临 床 药 学 。 E-mail:
          1624583840@qq.com                                   KEYWORDS    clinical  pharmacist;  type  2  diabetes  mellitus;
              # 通信作者 主任药师,硕士生导师。研究方向:临床药学、药事管                 full-cycle  management;  Delphi  method;  analytic  hierarchy
          理。E-mail:752557163@qq.com                           process


          · 92 ·    China Pharmacy  2026 Vol. 37  No. 1                                中国药房  2026年第37卷第1期
   97   98   99   100   101   102   103   104   105   106   107